Vikram Adhikarla

This study shows that intranasal LMNSC01 treatment reduces neuroimmune and neurovascular dysfunction after TBI by modulating ICAM-1 and CX3CL1 expression in both male and female rats.

Combining 177Lu-PSMA-617 radioligand therapy with PSCA-CAR T cells improves tumor control and survival in prostate cancer models by overcoming antigen heterogeneity and reshaping the immunosuppressive tumor microenvironment.

The paper develops an agent-based model to predict neural stem cell migration in mouse brains using multi-fiber tractography, showing injection location affects distribution and suggesting factors like chemotaxis may be important.

This paper develops a mathematical model to optimize targeted radionuclide therapy for multiple myeloma by identifying key principles for improving treatment efficacy while minimizing toxicity.